Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Recurrence 1 Immunoglobulin Light-chain Amyloidosis 1

Interventions

Dexamethasone 109 pomalidomide 53 Cyclophosphamide 52 Bortezomib 42 fludarabine phosphate 33 Lenalidomide 33 Peripheral Blood Stem Cell Transplantation 28 carfilzomib 26 Mycophenolic Acid 25 daratumumab 24 Calcium Dobesilate 24 Cyclosporine 22 Busulfan 21 Antilymphocyte Serum 20 Tacrolimus 19 Whole-Body Irradiation 18 Melphalan 17 Radiotherapy 15 Filgrastim 15 Methotrexate 14 fludarabine 12 Methylprednisolone 12 elotuzumab 11 Cord Blood Stem Cell Transplantation 11 selinexor 10 ixazomib 9 Etoposide 8 Thalidomide 7 Prednisone 7 Panobinostat 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × darlin protein, Dictyostelium × Plasma cell × Clear all

NCT03450057 2024-03-29

DARE

Hellenic Society of Hematology

Phase 2 Completed

38 enrolled 16 charts

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡